Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.19 -0.01 (-5.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Vistagen Therapeutics (VTGN) Total Current Liabilities (2009 - 2026)

Updated

Vistagen Therapeutics (VTGN) posted Total Current Liabilities of $8.43 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 38.2% from $13.64 million a year earlier and down 24.7% from the prior quarter.

Analysis

Vistagen Therapeutics (VTGN) Total Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Total Current Liabilities came in at $12.8 million, up 1.5% from FY2025.

  • Annual Total Current Liabilities has increased for three consecutive fiscal years, with a five-year compound annual growth rate of 25.0% (FY2021 to FY2026).
  • In prior fiscal years, Vistagen Therapeutics' Total Current Liabilities was $12.61 million in FY2025 (+146.2%), $5.12 million in FY2024 (+12.0%), $4.57 million in FY2023 (-20.7%) and $5.77 million in FY2022 (+37.6%).
  • The fiscal Q2 2027 figure stands as the lowest quarterly Total Current Liabilities since fiscal Q2 2025.
  • On a year-over-year basis, Total Current Liabilities increased in seven of the last eight quarters, with growth averaging 55.2%.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was fiscal Q2 2025, with growth of 158.6%; the weakest was fiscal Q1 2024, with a decline of 54.6%.
  • According to Business Quant data, Total Current Liabilities for the three prior fiscal quarters was $11.19 million (Q1 2027), $12.8 million (Q4 2026) and $13.53 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.26 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 47.00 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 55.46 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 43.10 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 28.80 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 23.23 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 12.00 Bn
9 Gsk 193.54 Bn 176.38 Bn - -27.42 Bn
10 Vistagen Therapeutics 7.34 Mn -151.60 Mn - 8.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 8.43 Mn
Jun 30, 2026 11.19 Mn
Mar 31, 2026 12.80 Mn
Dec 31, 2025 13.53 Mn
Sep 30, 2025 13.64 Mn
Jun 30, 2025 11.16 Mn
Mar 31, 2025 12.61 Mn
Dec 31, 2024 9.62 Mn
Sep 30, 2024 7.52 Mn
Jun 30, 2024 6.24 Mn
Mar 31, 2024 5.12 Mn
Dec 31, 2023 4.16 Mn
Sep 30, 2023 2.91 Mn
Jun 30, 2023 4.05 Mn
Mar 31, 2023 4.57 Mn
Dec 31, 2022 4.29 Mn
Sep 30, 2022 6.05 Mn
Jun 30, 2022 8.93 Mn
Mar 31, 2022 5.77 Mn
Dec 31, 2021 6.42 Mn
API Access

Vistagen Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=VTGN&period=max&api_key=YOUR_API_KEY